For the core programme (without medication), independent research published in The Lancet found that WeightWatchers participants lost around 2.6kg more than a self-directed group at 12 months
This content is not intended for self-diagnosis or treatment
The female images, combined with the objective measurements, shows that the average female in the reported study [2, 16] had substantial improvements in body size and shape along with the BRI health marker, moving closer to what might be considered target BMIs and BRIs
The emergence of GLP-1 medications has led to new product categories, including Nestle's Vital Pursuit, specifically marketed to this growing user base
Yucca Health's GLP-1 programs involve prescription medications that require evaluation by a licensed clinician
There is no clear consensus on when to initiate drug management for MALFD